The Mercedes CLA Shooting Brake is a distinctive variant in the CLA family that combines coupe-like styling with the added practicality of a compact wagon, offering a sporty design and greater cargo ...

Sarah is an experienced writer and editor enthusiastic about helping readers live their healthiest and happiest lives. Before joining Forbes Health, Sarah worked as a writer for various digital ...

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal. By Rebecca Robbins Hims & Hers, a major online provider of obesity medications, said ...

Add Yahoo as a preferred source to see more of our stories on Google. A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman ...

If you’ve felt frustrated by weight gain or a weight loss plateau in the years leading up to menopause, you’re not alone. "Starting in your 40s, you gain about one to two pounds every year," says ...

Top executives from drugmakers big and small told CNBC that the next phase of the obesity drug market will be defined by a broader range of treatment options and improved access for patients. CNBC ...

A Maryland truck driver suffered an “eye stroke” that left him blind, first in one eye and then the other. A Louisiana woman vomited for weeks before being diagnosed with a brain dysfunction typically ...

‘The Wrecking Crew’ star Dave Bautista focused on diet and exercise after gaining weight for a role Dimitrios Kambouris/Getty; Kayla Oaddams/Getty Dave Bautista gained weight for his role in the 2023 ...

Individuals seeking weight loss medications, including glucagon-like peptide 1 (GLP-1) agonists like Zepbound or Mounjaro, can now skip the doctor’s office and get prescriptions via virtual GLP-1 ...

Roughly a year after starting a weight loss drug, tennis champion Serena Williams says the medication has made her the healthiest she has ever been. Williams, 44, announced her exit from professional ...

Roche obesity drug shows 22.5% weight loss in Phase-II trial Roche focuses on catching Lilly in $150 billion obesity market Investors lukewarm on CT-388 results in crowded market The company said on ...